Explore the words cloud of the BRAV3 project. It provides you a very rough idea of what is the project "BRAV3" about.
The following table provides information about the project.
UNIVERSIDAD DE NAVARRA
|Coordinator Country||Spain [ES]|
|Total cost||8˙000˙000 €|
|EC max contribution||8˙000˙000 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|1||UNIVERSIDAD DE NAVARRA||ES (PAMPLONA)||coordinator||800˙500.00|
|2||INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA||PT (OEIRAS)||participant||770˙000.00|
|3||FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA||ES (BARCELONA)||participant||740˙000.00|
|4||UNIVERSITAIR MEDISCH CENTRUM UTRECHT||NL (UTRECHT)||participant||740˙000.00|
|5||UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT||DE (WURZBURG)||participant||683˙125.00|
|6||LEARTIKER, SCOOP||ES (MARKINA-XEMEIN)||participant||579˙375.00|
|7||UNIVERSIDAD DE ZARAGOZA||ES (ZARAGOZA)||participant||560˙000.00|
|8||EBERS MEDICAL TECHNOLOGY SL||ES (ZARAGOZA)||participant||559˙375.00|
|9||KATHOLIEKE UNIVERSITEIT LEUVEN||BE (LEUVEN)||participant||555˙250.00|
|10||TECHNISCHE UNIVERSITEIT EINDHOVEN||NL (EINDHOVEN)||participant||490˙000.00|
|11||BOSTON SCIENTIFIC LIMITED||IE (Galway)||participant||471˙750.00|
|12||PNO INNOVATION SL||ES (BARCELONA)||participant||458˙750.00|
|13||SERVICIO MADRILENO DE SALUD||ES (MADRID)||participant||441˙875.00|
|14||AE MEDICALIS BV||NL (WAALWIJK)||participant||150˙000.00|
Ischemic heart disease is the main cause of death in the EU, straining patients and economies. Regenerative Medicine has failed at delivering a definitive solution, and even the breakthrough of cell reprogramming, biomaterials or 3D printing, have not been able to find a curative solution. Generating a muscle with efficient pumping requires a careful recapitulation of the myocardial architecture. BRAV∃ is born with the ambition of shaping this quantum leap in the field. The overall concept is to provide a lasting functional support to injured hearts through the fabrication of regenerative personalized advanced tissue engineering-based biological ventricular assist devices (BioVADs). To do so, we will apply multimodal deep cardiac phenotyping, coupled to advanced Computational Modelling and biomechanical analysis in a large animal model of disease, to create a personalised 3D printable design. We will for the first time create a fibre-reinforced human heart-sized cardiac tissue able to recapitulate the low Young´s Modulus of the myocardium while withstanding pressures generated during the cardiac circle. Using the latest human induced pluripotent stem cell (hiPSC) technology and industrial-scale growth and differentiation, we will cellularize this novel human heart-sized constructs, creating a highly efficiently aligned cardiac tissue (including vasculature). BioVADs will be matured in in-Consortium built electromechanical stimulation bioreactors before transplantation in a porcine model of disease. We anticipate our BioVADs will constitute a one-shot regenerative treatment of IHD, decreasing the burden on healthcare providers and improving the quality of life of patients. Crucially, we will for the first time generate a wealth of information on heart development at a human scale. Delivering this novel application whilst developing the technological environment (bioreactor, chamber, pacemaker) will boost the capacity of the EU to grow economically and lead the field.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BRAV3" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BRAV3" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired PneumoniaRead More